↓ Skip to main content

Phase II, open-label, multicenter trial of crizotinib in Japanese patients with advanced non-small cell lung cancer harboring a MET gene alteration: Co-MET study

Overview of attention for article published in Trials, March 2020
Altmetric Badge

Mentioned by

reddit
1 Redditor

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
23 Mendeley